Spyre Therapeutics, Inc.
SYRE · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $0K | $0K | |
| Operating income | −$210M | −$209M | −0.5% |
| Net income | −$155M | −$208M | +25.4% |
Questions
- What was Spyre's revenue in FY2025?
- $0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Feb 2026.
- Was Spyre profitable in FY2025?
- No: net income was −$155M and operating income −$210M in FY2025.